Insilico Medicine Execs at CPIC Discuss AI Drug Discovery’s Tech and Clinical Breakthroughs
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug ...
Tag: Pharma.AI platform
BIO Europe 2025 | Insilico Advances Longevity Research with Breakthrough Multiparameter-Optimized Cardiometabolic Assets Powered by Generative AI
In a groundbreaking announcement set to reshape the landscape of cardiometabolic therapeutics, Insilico Medicine, a clinical-stage biotechnology company propelled by ...
Insilico Medicine Recognized as 2025 BostInno Fire Awards Honoree
In a remarkable demonstration of the transformative power of artificial intelligence in biotechnology, Insilico Medicine has been honored as a ...
Insilico Medicine Publishes Phase IIa Results in Nature Medicine on Rentosertib, Novel AI-Designed TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
In a groundbreaking advancement in pharmaceutical science, Insilico Medicine has unveiled the first proof-of-concept clinical validation of a drug discovered ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!